Home

What challenges population health decision makers face while managing patients with schizophrenia? How do they mitigate barriers?

What challenges population health decision makers face while managing patients with schizophrenia? What challenges worsened during COVID-19 pandemic? What strategies are recommended by decision makers to mitigate these challenges? My recent paper published in JMCP answers these and other questions. My recent paper titled “Schizophrenia population health management: perspectives of and lessons learned from population…

Is Telehealth Here to Stay?

A new report from researchers at the University of Michigan comprehensively looks at the telehealth trends, adoption, access, cost and quality, and user experience. The report is a work product of research from the Institute for Healthcare Policy and Innovation’s Telehealth Research Incubator and researchers from the University of Michigan.  Covid-19 has resulted in a…

Did treatment of opioid use disorder (OUD) among Medicaid enrollees change from 2014 to 2018?

A recent study published in the JAMA aims to understand the use of medications for OUD and potential indicators of quality of care in multiple US states. The research was conducted by ​​The Medicaid Outcomes Distributed Research Network (MODRN) led by Dr. Julie Donohue, Ph.D., chair and professor of the University of Pittsburgh Graduate School…

Machine Learning in Medication Adherence Detection

Artificial Intelligence (AI) and Machine Learning (ML) research and its application in various fields is reaching new heights everyday. There are numerous applications of these advanced technology from consumer products e.g. Apples FaceID, Personalization (recommendation systems) and education. A recent research published in Journal of Diabetes Science and Technology investigated ML based approach of measuring…

Loading…

Something went wrong. Please refresh the page and/or try again.